DOCSLIB.ORG

The Role of the Orphan Receptor SF-1 in the Development and Function of the Ovary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Role of the Orphan Receptor SF-1 in the Development and Function of the Ovary Vol. 10, No. 3 177 MINIREVIEW The role of the orphan receptor SF-1 in the development and function of the ovary Jaroslaw Mlynarczuk1, Robert Rekawiecki Institute of Animal Reproduction and Food Research of Polish Academy of Science, Olsztyn, Poland Received: 26 October 2009; accepted: 29 October 2010 SUMMARY The development of oocyte and ovulation require a precise synchronization at systemic and local levels. Nuclear receptors are involved in the regulation of these processes. In addition to the well-known nuclear receptors (e.g. receptors for estradiol, progesterone, glucocorticoids), a group of “orphan receptors” are distinguished within a receptor family. The orphan receptors are characterized by a lack of defined physiological ligands. Steroidogenic Factor 1 (SF-1, NR5A1) is a member of the orphan receptor group and is in- volved in the regulation of reproductive processes. The SF-1 structure is similar to that of the steroid receptors but does not have a modulatory domain. The SF-1 as a transcription factor may interact with genes in three main ways: a/ by a mechanism typical for nuclear receptors, encompassing homodimerization of SF-1 units, b/ by a formation heterodimers with other 1Corresponding author: Intitute of Animal Reproduction and Food Research of Polish Academy of Science, Tuwima 10, 10–747 Olsztyn, Poland, [email protected] Copyright © 2010 by the Society for Biology of Reproduction 178 SF-1 in the ovary nuclear receptors, and c/ by action as a monomer. During fetal develop- ment, the SF-1, is responsible for differentiation of the gonads and, during the postnatal period, it is responsible for the increase in the expression of genes involved in steroidogenesis. Knock-out of SF-1 gene leads to a rapid death of newly born mice with symptoms of severe adrenal insuf- ficiency. In humans, SF-1 dysfunction causes an adrenal insufficiency and infertility. Learning of the SF-1 and other orphan receptors’ action mechanisms, will allow the creation of specific drugs, helpful in prevent- ing some diseases of the female reproductive tract. Reproductive Biology 2010 10 3: 177–193. Key words: orphan receptors, SF-1 receptor, reproduction, ovaries. INTRODUCTION The main function of mammalian ovaries is the production of matured female gametes – oocytes. Development and maturation of oocytes is a multistage process which requires the timed action of many regulatory factors at both systemic and local levels. Nuclear receptors (NR), among other receptors, are engaged in the transmission of signals between cells. The NR superfamily of NR is a group of transcription factors which control the gene expression after activation by steroid and thyroid hormones, vitamin D and their deriva- tives, cholesterol and retinoic acid [37]. NR serves as an interface for signals from the whole body to a cell genome [58]. In addition to classical NR [e.g. steroid receptors, thyroid hormone (TR) receptors, vitamin D (VDR) recep- tors], there are numerous orphan receptors [20, 21]. Identification and func- tion of the latter was possible thanks to development of so-called reverse endocrinology [33]. Genes encoding unknown NR or putative response elements were determined during the mapping of the human and animal genomes. There are 48 NR in the human and 49 NR in the mouse genome [2, 41]. A natural ligand for the first discovered orphan receptor – estrogen- related receptor (ERRα; [21]) has not been identified yet. Experimental data indicates that many estrogenic substances (diethylstilbestrol, organochlorine pesticides, phytoestrogens) may be ligands of ERRα [2]. Mlynarczuk & Rekawiecki 179 Nuclear receptors are classified into seven groups (NR0 - NR6) according to their sequence homology and phylogenetic relationships. Steroidogenic factor 1 (SF-1, AD4BP) is one of the NR family and belongs to the NR5 group and NR5A subgroup. Due to this and to the fact that SF-1 was the first receptor discovered in the subgroup, its official name is NR5A1. But its common name (SF-1) is also used in scientific literature. Another member of the NR5 group is liver receptor homologue-1 (LHR-1, NR5A2). The nuclear receptors are also classified according to their physiological ligands and potential function (fig. 1; [2]): 1. “endocrine” receptors: steroid hormone receptors, TR, VDR, retinoic acid receptors (RARs) characterized by high affinity for their ligands (Kd ≥ nM) and high transcriptional activity; 2. “true” orphan receptors: their physiological ligands are unknown, but they may have synthetic ligands. These receptors are often functional inhibitors of transcriptional activity of other NR however, it is unknown whether this inhibition is ligand-dependent or -independent [30]; 3. “adopted” orphan receptors: orphan receptors which were adopted after the discovery of their ligands. Compared to the endocrine receptors, these receptors are characterized by a lower affinity for their ligands and lower transcriptional activity. Within the adopted orphan receptor group, “enigmatic” orphan receptors were further distinguished. Some ligands of the enigmatic orphan receptors have been identified, but the nature of the ligand-dependent activation of these receptors is difficult to associ- ate with any physiological process. SF-1 is an example of an enigmatic orphan receptor with sphingosine as its natural ligand [64, 65]. The main pathway of SF-1 action is typical to that of endocrine receptors such as estradiol (ER) or progesterone (PR) receptors (fig. 3a). Steroid hor- mone receptors and other “endocrine” receptors diffuse through the plasma membrane of their target cells and bind to the specific NR subunits. Then, the ligand-activated subunits dimerize and acquire the transcriptional activity. Nuclear receptors may form homo- (dimerization of the same NR subunits) or heterodimers (dimerization of different NR subunits). After translocation to the nucleus, dimer binds to a specific hormone response element present in the promoter of a target gene and affects the gene’s transcription. 180 SF-1 in the ovary Figure 1. Classification of nuclear receptors. CAR: constitutive androgen receptor [NR1I1]; COUP-TF: chicken ovoalbumin upstream promoter – transcription factor [NR2F]; DAX-1: dosage-sensitive sex reversal, adrenal hypoplasia critical region on chromosome X, gene 1 [NR0B1]; ERR: estrogen related receptor [NR3B]; PNR: photoreceptor cell-specific nuclear receptor [NR2E3]; PPAR: peroxisome proliferator-activated receptor [NR1C], PXR: pregnane X receptor [NR1I2], ROR: RAR-related orphan receptor [NR1F], RXR: retinoid X receptor [NR2B], SF-1: steroidogenic factor-1 [NR5A1]. STRUCTURE OF SF- 1 The existence of SF-1 was predicted in 1984 after the identification of cDNA of bovine 21-hydroxylase and cholesterol side-chain cleavage monooxyge- nase (P450scc; [46, 68]). Two years later the response element for SF-1 was identified in the promoter region of the 21-hydroxylase gene [25, 52]. Next, the protein interacting with the response element for SF-1 was recognized [47, 54], SF-1 cDNA was cloned and the amino acid sequence of SF-1 protein was described [28]. SF-1 is a phylogenetic old structure. As high as 75–85% amino acid se- quence similarity was observed between the SF-1 receptor in different mam- mals and FTZ-F1, a SF-1 homolog discovered in Drosophilla melanogaster [56]. The SF-1 is functionally divided into three domains: DNA binding Mlynarczuk & Rekawiecki 181 Figure 2. Structure of SF-1 and classic nuclear receptor. AF-1/MD: activation func- tion sequence 1/modulatory domain; AF-2: activation function sequence-2; DBD: DNA binding domain, LBD: ligand binding domain; ZF1, ZF2: zinc fingers. domain (DBD, region C), “hinge” region (flexible region, region D) and li- gand binding domain (LBD, region E; fig. 2). In contrast to other NR, SF-1 does not possess A/B region and its modulatory domain (MD) is extremely shortened (fig. 2). Hence, SF-1 does not have the ligand-independent activa- tion function 1 sequence (AF-1). However, the short MD present in SF-1 may be phosphorylated by MAP-kinases [19] and, thus, it may join cofactors (i.e. SOX9 or WT-1) affecting SF-1 transcriptional activity [16, 50]. The DNA binding domain is the most conserved part of SF-1. It con- tains DNA-binding motif composed of two zinc-chelating modules (zinc fingers) that coordinate the interaction between the receptor and hormone response element (HRE). The “hinge” region is partially responsible for homo- or heterodimerization. Miscellaneous cofactors may bind to this region and affect SF-1 transcriptional activity [60]. The ligand binding domain (LBD, domain E) is composed of a ligand binding pocket, di- merization site, activation function 2 sequence (AF-2) and cofactor bind- ing site. The domain mediates dimerization, ligand-induced activation as well as ligand-reversed transcriptional silencing. The enhancement of SF-1 transcriptional activity might be caused by Ptx-1 protein which binds to LBD domain [62]. Because SF-1 does not have a functional 182 SF-1 in the ovary domain A/B and AF-1 sequence (fig. 2), the activation of AF-2 sequence is sufficient for full transcriptional activity of the receptor [55]. In mice, three isoforms of SF-1 (ELP1– ELP3) were found as a result of mRNA SF-1 alternative splicing [51]. The existence of SF-1 isoforms was not confirmed in other mammals. MECHANISM OF SF-1 ACTION More than one pathway may be involved in the regulation of SF-1 tran- scriptional activity. The main pathway starts with the homodimerization of SF-1 units after ligand binding. This is followed by the activation of the transcription of genes containing promoters with the appropriate palindromic response elements [55]. The SF-1 response element is com- posed of two half-palindrome sequences: 5’-AGGTCANNNTGACCT-3’ [5]. Another pathway starts with the heterodimerization of SF-1 with other NR. These heterodimers may be formed by NR characterized by certain transcriptional activity (Retinoid X Receptors-RXR; 9-cis-Retinoid Acid Receptor-RAR) as well as by NR without such activity (DAX-1 of NR0 group; fig.
Load more

Recommended publications
  • Rep 467 Morrish & Sinclair
    Reproduction (2002) 124, 447–457 Review Vertebrate sex determination: many means to an end Bronwyn C. Morrish and Andrew H. Sinclair* Murdoch Children’s Research Institute, Royal Children’s Hospital, Flemington Rd, Melbourne, Victoria 3052, Australia The differentiation of a testis or ovary from a bipotential gonadal primordium is a develop- mental process common to mammals, birds and reptiles. Since the discovery of SRY, the Y-linked testis-determining gene in mammals, extensive efforts have failed to find its orthologue in other vertebrates, indicating evolutionary plasticity in the switch that triggers sex determination. Several other genes are known to be important for sex determination in mammals, such as SOX9, AMH, WT1, SF1, DAX1 and DMRT1. Analyses of these genes in humans with gonadal dysgenesis, mouse models and using in vitro cell culture assays have revealed that sex determination results from a complex interplay between the genes in this network. All of these genes are conserved in other vertebrates, such as chickens and alligators, and show gonad-specific expression in these species during the period of sex determination. Intriguingly, the sequence, sex specificity and timing of expression of some of these genes during sex determination differ among species. This finding indicates that the interplay between genes in the regulatory network leading to gonad development differs between vertebrates. However, despite this, the development of a testis or ovary from a bipotential gonad is remarkably similar across vertebrates. The existence of two sexes is nearly universal in the animal and alligators. Ectopic administration of oestrogen or kingdom and although gonadal morphogenesis is remark- inhibitors of oestrogen synthesis during a critical period of ably similar across vertebrates, the sex-determining mecha- gonadogenesis in chickens and alligators can feminize or nism varies considerably.
    [Show full text]
  • Analysis of the Gene Coding for Steroidogenic Factor 1 (SF1, NR5A1) in a Cohort of 50 Egyptian Patients with 46,XY Disorders of Sex Development
    S Tantawy and others SF1 in Egyptians with 46,XY DSD 170:5 759–767 Clinical Study Analysis of the gene coding for steroidogenic factor 1 (SF1, NR5A1) in a cohort of 50 Egyptian patients with 46,XY disorders of sex development Sally Tantawy1,2, Inas Mazen2, Hala Soliman3, Ghada Anwar4, Abeer Atef4, Mona El-Gammal2, Ahmed El-Kotoury2, Mona Mekkawy5, Ahmad Torky2, Agnes Rudolf1, Pamela Schrumpf1, Annette Gru¨ ters1, Heiko Krude1, Marie-Charlotte Dumargne6, Rebekka Astudillo1, Anu Bashamboo6, Heike Biebermann1 and Birgit Ko¨ hler1 1Institute of Experimental Paediatric Endocrinology, University Children’s Hospital, Charite´ , Humboldt University, Correspondence Berlin, Germany, 2Department of Clinical Genetics and 3Department of Medical Molecular Genetics, Division of should be addressed Human Genetics and Genome Research, National Research Centre, Cairo, Egypt, 4Department of Paediatrics, to S Tantawy Cairo University, Cairo, Egypt, 5Department of Cytogenetics, Division of Human Genetics and Genome Research, Email National Research Centre, Cairo, Egypt and 6Human Developmental Genetics, Institut Pasteur, Paris, France [email protected] Abstract Objective: Steroidogenic factor 1 (SF1, NR5A1) is a key transcriptional regulator of genes involved in the hypothalamic– pituitary–gonadal axis. Recently, SF1 mutations were found to be a frequent cause of 46,XY disorders of sex development (DSD) in humans. We investigate the frequency of NR5A1 mutations in an Egyptian cohort of XY DSD. Design: Clinical assessment, endocrine evaluation and genetic analysis of 50 Egyptian XY DSD patients (without adrenal insufficiency) with a wide phenotypic spectrum. Methods: Molecular analysis of NR5A1 gene by direct sequencing followed by in vitro functional analysis of the European Journal of Endocrinology two novel missense mutations detected.
    [Show full text]
  • The Impact of Skeletal Muscle Erα on Mitochondrial Function And
    Copyedited by: oup MINI REVIEW The Impact of Skeletal Muscle ERα on Mitochondrial Function and Metabolic Health Downloaded from https://academic.oup.com/endo/article-abstract/161/2/bqz017/5735479 by University of Southern California user on 19 February 2020 Andrea L. Hevener1,2, Vicent Ribas1, Timothy M. Moore1, and Zhenqi Zhou1 1David Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes, and Hypertension, University of California, Los Angeles, California 90095; and 2Iris Cantor-UCLA Women’s Health Research Center, University of California, Los Angeles, California 90095 ORCiD numbers: 0000-0003-1508-4377 (A. L. Hevener). The incidence of chronic disease is elevated in women after menopause. Increased expression of ESR1 (the gene that encodes the estrogen receptor alpha, ERα) in muscle is highly associated with metabolic health and insulin sensitivity. Moreover, reduced muscle expression levels of ESR1 are observed in women, men, and animals presenting clinical features of the metabolic syndrome (MetSyn). Considering that metabolic dysfunction elevates chronic disease risk, including type 2 diabetes, heart disease, and certain cancers, treatment strategies to combat metabolic dysfunction and associated pathologies are desperately needed. This review will provide published work supporting a critical and protective role for skeletal muscle ERα in the regulation of mitochondrial function, metabolic homeostasis, and insulin action. We will provide evidence that muscle-selective targeting of ERα may be effective for the preservation of mitochondrial and metabolic health. Collectively published findings support a compelling role for ERα in the control of muscle metabolism via its regulation of mitochondrial function and quality control. Studies identifying ERα-regulated pathways essential for disease prevention will lay the important foundation for the design of novel therapeutics to improve metabolic health of women while limiting secondary complications that have historically plagued traditional hormone replacement interventions.
    [Show full text]
  • A Primer on the Use of Mouse Models for Identifying Direct Sex Chromosome Effects That Cause Sex Differences in Non-Gonadal Tissues Paul S
    Burgoyne and Arnold Biology of Sex Differences (2016) 7:68 DOI 10.1186/s13293-016-0115-5 REVIEW Open Access A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues Paul S. Burgoyne1 and Arthur P. Arnold2* Abstract In animals with heteromorphic sex chromosomes, all sex differences originate from the sex chromosomes, which are the only factors that are consistently different in male and female zygotes. In mammals, the imbalance in Y gene expression, specifically the presence vs. absence of Sry, initiates the differentiation of testes in males, setting up lifelong sex differences in the level of gonadal hormones, which in turn cause many sex differences in the phenotype of non-gonadal tissues. The inherent imbalance in the expression of X and Y genes, or in the epigenetic impact of X and Y chromosomes, also has the potential to contribute directly to the sexual differentiation of non-gonadal cells. Here, we review the research strategies to identify the X and Y genes or chromosomal regions that cause direct, sexually differentiating effects on non-gonadal cells. Some mouse models are useful for separating the effects of sex chromosomes from those of gonadal hormones. Once direct “sex chromosome effects” are detected in these models, further studies are required to narrow down the list of candidate X and/or Y genes and then to identify the sexually differentiating genes themselves. Logical approaches to the search for these genes are reviewed here. Keywords: Sex determination, Sexual differentiation, Sex chromosomes, X chromosome, Y chromosome, Testosterone, Estradiol, Gonadal hormones Background complement, including differences in the parental source In animals with an unmatched (heteromorphic) pair of of the X chromosome.
    [Show full text]
  • The Spectrum of Phenotypes Associated with Mutations In
    European Journal of Endocrinology (2009) 161 237–242 ISSN 0804-4643 CLINICAL STUDY The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency Birgit Ko¨hler, Lin Lin1, Inas Mazen2, Cigdem Cetindag, Heike Biebermann, Ilker Akkurt3, Rainer Rossi4, Olaf Hiort5, Annette Gru¨ters and John C Achermann1 Department of Pediatric Endocrinology, University Children’s Hospital, Charite´, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany, 1Developmental Endocrinology Research Group, UCL Institute of Child Health, University College London, London, UK, 2Department of Clinical Genetics, National Research Center, Cairo, Egypt, 3Children’s Hospital Altona, Hamburg, Germany, 4Children’s Hospital Neuko¨lln, Berlin, Germany and 5Division of Pediatric Endocrinology, Department of Pediatrics, University of Lu¨beck, Lu¨beck, Germany (Correspondence should be addressed to B Ko¨hler; Email: [email protected]) Abstract Objective: Hypospadias is a frequent congenital anomaly but in most cases an underlying cause is not found. Steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) is a key regulator of human sex development and an increasing number of SF-1 (NR5A1) mutations are reported in 46,XY disorders of sex development (DSD). We hypothesized that NR5A1 mutations could be identified in boys with hypospadias. Design and methods: Mutational analysis of NR5A1 in 60 individuals with varying degrees of hypospadias from the German DSD network. Results: Heterozygous NR5A1 mutations were found in three out of 60 cases. These three individuals represented the most severe end of the spectrum studied as they presented with penoscrotal hypospadias, variable androgenization of the phallus and undescended testes (three out of 20 cases (15%) with this phenotype).
    [Show full text]
  • Expression Profiling of Sexually Dimorphic Genes in the Japanese
    www.nature.com/scientificreports OPEN Expression profling of sexually dimorphic genes in the Japanese quail, Coturnix japonica Miki Okuno1,5, Shuntaro Miyamoto2,5, Takehiko Itoh1, Masahide Seki3, Yutaka Suzuki3, Shusei Mizushima2,4 & Asato Kuroiwa2,4* Research on avian sex determination has focused on the chicken. In this study, we established the utility of another widely used animal model, the Japanese quail (Coturnix japonica), for clarifying the molecular mechanisms underlying gonadal sex diferentiation. In particular, we performed comprehensive gene expression profling of embryonic gonads at three stages (HH27, HH31 and HH38) by mRNA-seq. We classifed the expression patterns of 4,815 genes into nine clusters according to the extent of change between stages. Cluster 2 (characterized by an initial increase and steady levels thereafter), including 495 and 310 genes expressed in males and females, respectively, contained fve key genes involved in gonadal sex diferentiation. A GO analysis showed that genes in this cluster are related to developmental processes including reproductive structure development and developmental processes involved in reproduction were signifcant, suggesting that expression profling is an efective approach to identify novel candidate genes. Based on RNA-seq data and in situ hybridization, the expression patterns and localization of most key genes for gonadal sex diferentiation corresponded well to those of the chicken. Our results support the efectiveness of the Japanese quail as a model for studies gonadal sex diferentiation in birds. In birds, males are homogametic (ZZ) and females are heterogametic (ZW). Te sex determination mechanism involving gene(s) on the sex chromosome is highly conserved among birds. In chickens, sex determination is thought to occur afer embryonic day (E) 4.5, corresponding to Hamburger and Hamilton stage1 24 (HH24).
    [Show full text]
  • Role of Estrogen Receptor-Β in Endometriosis
    39 Role of Estrogen Receptor-β in Endometriosis Serdar E. Bulun, M.D. 1 Diana Monsavais, B.S. 1 Mary Ellen Pavone, M.D. 1 Matthew Dyson, Ph.D. 1 Qing Xue, M.D., Ph.D. 2 Erkut Attar, M.D. 3 Hideki Tokunaga, M.D., Ph.D. 4 Emily J. Su, M.D., M.S. 1 1 Division of Reproductive Biology Research, Department Obstetrics Address for correspondence and reprint requests Serdar E. Bulun, and Gynecology, Northwestern University Feinberg School of M.D., Division of Reproductive Biology Research, Department Medicine, Chicago, Illinois Obstetrics and Gynecology, Northwestern University Feinberg School 2 Department of Obstetrics and Gynecology, First Hospital of Peking of Medicine, 303 E. Superior Street, 4-123, Chicago, IL 60611 University, Beijing, P.R. China (e-mail: [email protected]). 3 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Istanbul University Capa School of Medicine, Istanbul, Turkiye 4 Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Sendai, Japan Semin Reprod Med 2012; 30:39–45 Abstract Endometriosis is an estrogen-dependent disease. The biologically active estrogen, estradiol, aggravates the pathological processes (e.g., inflammation and growth) and the symptoms (e.g., pain) associated with endometriosis. Abundant quantities of estradiol are available for endometriotic tissue via several mechanisms including local Keywords aromatase expression. The question remains, then, what mediates estradiol action. ► ER-β Because estrogen receptor (ER)β levels in endometriosis are >100 times higher than ► nuclear receptor those in endometrial tissue, this review focuses on this nuclear receptor. Deficient ► estrogen methylation of the ERβ promoter results in pathological overexpression of ERβ in ► DNA methylation endometriotic stromal cells.
    [Show full text]
  • Genetic Disorders of Nuclear Receptors
    Genetic disorders of nuclear receptors John C. Achermann, … , Louise Fairall, Krishna Chatterjee J Clin Invest. 2017;127(4):1181-1192. https://doi.org/10.1172/JCI88892. Review Series Following the first isolation of nuclear receptor (NR) genes, genetic disorders caused by NR gene mutations were initially discovered by a candidate gene approach based on their known roles in endocrine pathways and physiologic processes. Subsequently, the identification of disorders has been informed by phenotypes associated with gene disruption in animal models or by genetic linkage studies. More recently, whole exome sequencing has associated pathogenic genetic variants with unexpected, often multisystem, human phenotypes. To date, defects in 20 of 48 human NR genes have been associated with human disorders, with different mutations mediating phenotypes of varying severity or several distinct conditions being associated with different changes in the same gene. Studies of individuals with deleterious genetic variants can elucidate novel roles of human NRs, validating them as targets for drug development or providing new insights into structure-function relationships. Importantly, human genetic discoveries enable definitive disease diagnosis and can provide opportunities to therapeutically manage affected individuals. Here we review germline changes in human NR genes associated with “monogenic” conditions, including a discussion of the structural basis of mutations that cause distinctive changes in NR function and the molecular mechanisms mediating pathogenesis. Find the latest version: https://jci.me/88892/pdf The Journal of Clinical Investigation REVIEW SERIES: NUCLEAR RECEPTORS Series Editor: Mitchell A. Lazar Genetic disorders of nuclear receptors John C. Achermann,1 John Schwabe,2 Louise Fairall,2 and Krishna Chatterjee3 1Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
    [Show full text]
  • Regulation of Cytochrome P450 (CYP) Genes by Nuclear Receptors Paavo HONKAKOSKI*1 and Masahiko NEGISHI† *Department of Pharmaceutics, University of Kuopio, P
    Biochem. J. (2000) 347, 321–337 (Printed in Great Britain) 321 REVIEW ARTICLE Regulation of cytochrome P450 (CYP) genes by nuclear receptors Paavo HONKAKOSKI*1 and Masahiko NEGISHI† *Department of Pharmaceutics, University of Kuopio, P. O. Box 1627, FIN-70211 Kuopio, Finland, and †Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, NIEHS, National Institutes of Health, Research Triangle Park, NC 27709, U.S.A. Members of the nuclear-receptor superfamily mediate crucial homoeostasis. This review summarizes recent findings that in- physiological functions by regulating the synthesis of their target dicate that major classes of CYP genes are selectively regulated genes. Nuclear receptors are usually activated by ligand binding. by certain ligand-activated nuclear receptors, thus creating tightly Cytochrome P450 (CYP) isoforms often catalyse both formation controlled networks. and degradation of these ligands. CYPs also metabolize many exogenous compounds, some of which may act as activators of Key words: endobiotic metabolism, gene expression, gene tran- nuclear receptors and disruptors of endocrine and cellular scription, ligand-activated, xenobiotic metabolism. INTRODUCTION sex-, tissue- and development-specific expression patterns which are controlled by hormones or growth factors [16], suggesting Overview of the cytochrome P450 (CYP) superfamily that these CYPs may have critical roles, not only in elimination CYPs constitute a superfamily of haem-thiolate proteins present of endobiotic signalling molecules, but also in their production in prokaryotes and throughout the eukaryotes. CYPs act as [17]. Data from CYP gene disruptions and natural mutations mono-oxygenases, with functions ranging from the synthesis and support this view (see e.g. [18,19]). degradation of endogenous steroid hormones, vitamins and fatty Other mammalian CYPs have a prominent role in biosynthetic acid derivatives (‘endobiotics’) to the metabolism of foreign pathways.
    [Show full text]
  • Ubiquitination and Sumoylation of Pregnane X Receptor
    UBIQUITINATION AND SUMOYLATION OF PREGNANE X RECEPTOR By Mengxi Sun Submitted to the graduate degree program in Pharmacology and Toxicology and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. ________________________________ Chairperson Dr. Jeff Staudinger ________________________________ Dr. Rick Dobrowsky ________________________________ Dr. Alex Moise ________________________________ Dr. Honglian Shi ________________________________ Dr. Kristi Neufeld Date Defended: 1/8/2015 The Dissertation Committee for Mengxi Sun certifies that this is the approved version of the following dissertation: UBIQUITINATION AND SUMOYLATION OF PREGNANE X RECEPTOR ________________________________ Chairperson Dr. Jeff Staudinger Date approved: 1/8/2015 ii Abstract Pregnane X receptor (PXR, NR1I2) is a ligand-activated nuclear receptor (NR) superfamily member expressed at high levels in the liver and intestine of mammals. PXR can be activated by a broad range of structurally diverse xenobiotics and endobiotics. As a key regulator of xenobiotic metabolism and clearance, activated PXR up-regulates the expression of genes encoding phase I (oxidation) and phase II (conjugation) metabolizing enzymes and phase III transporters to increase the metabolism and clearance of drugs and xenobiotics from the body, thus protecting the body from potential toxic insults. Besides xenobiotic metabolism and clearance, activation of PXR also involves in the regulation of many other important biochemical pathways, like inflammation and bile acid homeostasis. While ligand-binding is the primary mechanism for NRs activation, recent research indicates that post-translational modifications of NRs also help to determine their activities under different physiological conditions and represent new modes of regulation for NRs. Studies on post-translational modifications of PXR have just begun to emerge, how post-translational modifications regulate PXR activity is not well-understood.
    [Show full text]
  • Genetic Landscape of Nonobstructive Azoospermia and New Perspectives for the Clinic
    Journal of Clinical Medicine Review Genetic Landscape of Nonobstructive Azoospermia and New Perspectives for the Clinic Miriam Cerván-Martín 1,2, José A. Castilla 2,3,4, Rogelio J. Palomino-Morales 2,5 and F. David Carmona 1,2,* 1 Departamento de Genética e Instituto de Biotecnología, Universidad de Granada, Centro de Investigación Biomédica (CIBM), Parque Tecnológico Ciencias de la Salud, Av. del Conocimiento, s/n, 18016 Granada, Spain; [email protected] 2 Instituto de Investigación Biosanitaria ibs.GRANADA, Av. de Madrid, 15, Pabellón de Consultas Externas 2, 2ª Planta, 18012 Granada, Spain; [email protected] (J.A.C.); [email protected] (R.J.P.-M.) 3 Unidad de Reproducción, UGC Obstetricia y Ginecología, HU Virgen de las Nieves, Av. de las Fuerzas Armadas 2, 18014 Granada, Spain 4 CEIFER Biobanco—NextClinics, Calle Maestro Bretón 1, 18004 Granada, Spain 5 Departamento de Bioquímica y Biología Molecular I, Universidad de Granada, Facultad de Ciencias, Av. de Fuente Nueva s/n, 18071 Granada, Spain * Correspondence: [email protected]; Tel.: +34-958-241-000 (ext 20170) Received: 29 December 2019; Accepted: 16 January 2020; Published: 21 January 2020 Abstract: Nonobstructive azoospermia (NOA) represents the most severe expression of male infertility, involving around 1% of the male population and 10% of infertile men. This condition is characterised by the inability of the testis to produce sperm cells, and it is considered to have an important genetic component. During the last two decades, different genetic anomalies, including microdeletions of the Y chromosome, karyotype defects, and missense mutations in genes involved in the reproductive function, have been described as the primary cause of NOA in many infertile men.
    [Show full text]
  • Developmental Expression of Steroidogenic Factor 1 in a Turtle with Temperature-Dependent Sex Determination
    General and Comparative Endocrinology 116, 336–346 (1999) Article ID gcen.1999.7360, available online at http://www.idealibrary.com on Developmental Expression of Steroidogenic Factor 1 in a Turtle with Temperature-Dependent Sex Determination Alice Fleming,* Thane Wibbels,† James K. Skipper,* and David Crews*,1 *Section of Integrative Biology, University of Texas at Austin, Austin, Texas 78712; and †Department of Biology, University of Alabama at Birmingham, Birmingham, Alabama 35294-1170 Accepted July 24, 1999 A variety of reptiles possess temperature-dependent sex indicating possible homologous functions. ௠ 1999 Academic determination (TSD) in which the incubation tempera- Press ture of a developing egg determines the gonadal sex. Key Words: steroidogenic factor 1, SF-1; Ad4BP; Current evidence suggests that temperature signals may FTZ-F1; reptile; turtle; Trachemys scripta; temperature- be transduced into steroid hormone signals with estro- dependent sex determination. gens directing ovarian differentiation. Steroidogenic fac- tor 1 (SF-1) is one component of interest because it regulates the expression of steroidogenic enzymes in INTRODUCTION mammals and is differentially expressed during develop- ment of testis and ovary. Northern blot analysis of SF-1 in developing tissues of the red-eared slider turtle Gonadal sex of species with temperature-dependent (Trachemys scripta), a TSD species, detected a single sex determination (TSD) is determined by the tempera- primary SF-1 transcript of approximately 5.8 kb across ture at which their eggs are incubated. In the red-eared all stages of development examined. Analysis by in situ slider turtle (Trachemys scripta), only males are pro- hybridization indicated nearly equivalent SF-1 expres- duced when eggs are incubated at 26°C, and only sion in early, bipotential gonads at male (26ЊC)- and females are produced at 31°C (Bull et al., 1982).
    [Show full text]